DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mirtazapine (Mirtazapine) - Fall - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Fall (80)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mirtazapine where reactions include fall. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 80   Next >>

Possible Mirtazapine side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-17

Patient: 69 year old female, weighing 64.0 kg (140.8 pounds)

Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1 mg, tid, 1mg three times per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-29
    End date: 2012-05-23

Metoclopramide Hydrochloride
    Dosage: 10 mg, as required
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-06
    End date: 2011-09-01

Mirtazapine
    Dosage: 30 mg, daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Paroxetine HCL
    Dosage: 20 mg, bid
    Administration route: Oral
    Indication: Depression
    Start date: 1997-07-07
    End date: 2011-12-06

Propranolol
    Dosage: 10 mg, 10mg six times per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Tetrabenazine
    Dosage: 4.5 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-28
    End date: 2012-03-20

Other drugs received by patient: Ramipril; Bendroflumethiazide; Beconase; Fenofibrate; Lansoprazole; Atorvastatin; Acrivastine



Possible Mirtazapine side effects in 69 year old female

Reported by a consumer/non-health professional from United Kingdom on 2012-08-16

Patient: 69 year old female, weighing 64.0 kg (140.8 pounds)

Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-29
    End date: 2012-05-23

Metoclopramide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-06
    End date: 2011-09-01

Mirtazapine
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Mirtazapine

Paroxetine HCL
    Administration route: Oral
    Indication: Depression
    Start date: 1997-07-07

Paroxetine HCL
    Administration route: Oral
    Start date: 2001-02-01
    End date: 2010-05-01

Paroxetine HCL
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-06

Paroxetine HCL
    Administration route: Oral
    Start date: 2010-07-01
    End date: 2011-09-01

Propranolol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Tetrabenazine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-28
    End date: 2012-03-20

Other drugs received by patient: Atorvastatin; Beconase; Fenofibrate; Ramipril; Bendroflumethiazide; Lansoprazole; Acrivastine



Possible Mirtazapine side effects in 69 year old female

Reported by a physician from United Kingdom on 2012-08-14

Patient: 69 year old female, weighing 64.0 kg (140.8 pounds)

Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 3 milligram daily;
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-29
    End date: 2012-05-23

Lorazepam
    Dosage: 1.5 milligram daily;
    Start date: 2011-01-01

Metoclopramide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-06
    End date: 2011-09-01

Mirtazapine
    Dosage: 30 milligram daily;
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Mirtazapine
    Dosage: 15 milligram daily;

Paroxetine HCL
    Administration route: Oral
    Indication: Depression
    Start date: 1997-07-07
    End date: 2011-12-06

Paroxetine HCL
    Dosage: .5 tablet daily;
    Administration route: Oral
    Start date: 2001-02-01
    End date: 2010-05-01

Paroxetine HCL
    Dosage: 40 milligram daily;
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-06

Paroxetine HCL
    Dosage: 20 milligram daily;
    Administration route: Oral
    Start date: 2010-07-01
    End date: 2011-09-01

Propranolol
    Dosage: 60 milligram daily;
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Tetrabenazine
    Dosage: 4.5 milligram daily;
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-28
    End date: 2012-03-20

Other drugs received by patient: Lansoprazole; Atorvastatin; Acrivastine; Beconase; Bendroflumethiazide; Fenofibrate; Ramipril



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-27

Patient: female

Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1 mg, tid, 1mg three times per day
    Indication: Product Used FOR Unknown Indication

Metoclopramide Hydrochloride
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 30 mg, daily
    Indication: Product Used FOR Unknown Indication

Propranolol
    Dosage: 10 mg, 10mg six times per day
    Indication: Product Used FOR Unknown Indication

Seroxat
    Dosage: 20 mg, bid, 20mg twice per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Tetrabenazine
    Dosage: 4.5mg per day
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Atorvastatin; Omeprazole; Acrivastine; Fenofibrate; Bendroflumethiazide; Ramipril; Beconase



Possible Mirtazapine side effects in female

Reported by a physician from United Kingdom on 2012-07-26

Patient: female, weighing 64.0 kg (140.8 pounds)

Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1mg three times per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-29
    End date: 2012-05-23

Metoclopramide
    Dosage: 10mg as required
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-06
    End date: 2011-09-01

Mirtazapine
    Dosage: 30mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Paroxetine Hydrochloride
    Administration route: Oral
    Indication: Depression
    Start date: 1997-07-07
    End date: 2011-12-06

Propranolol
    Dosage: 10mg six times per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-01

Tetrabenazine
    Dosage: 4.5mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-28
    End date: 2012-03-20

Other drugs received by patient: Acrivastine; Bendroflumethiazide; Ramipril; Lansoprazole; Beconase; Fenofibrate; Atorvastatin



Possible Mirtazapine side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-07-26

Patient: female

Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Indication: Product Used FOR Unknown Indication

Metoclopramide
    Indication: Product Used FOR Unknown Indication

Mirtazapine

Mirtazapine
    Indication: Product Used FOR Unknown Indication

Paroxetine Hydrochloride
    Administration route: Oral

Paroxetine Hydrochloride
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Paroxetine Hydrochloride
    Administration route: Oral
    Start date: 2011-11-01

Propranolol
    Indication: Product Used FOR Unknown Indication

Tetrabenazine
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Omeprazole; Beconase; Bendroflumethiazide; Fenofibrate; Ramipril; Acrivastine; Atorvastatin



Possible Mirtazapine side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-07-25

Patient: female

Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Indication: Product Used FOR Unknown Indication

Lorazepam
    Dosage: 1.5 milligram;
    Start date: 2011-01-01

Metoclopramide
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 30 milligram;
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 15 milligram;

Paroxetine Hydrochloride
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Paroxetine Hydrochloride
    Dosage: 20 milligram;
    Administration route: Oral
    Start date: 2011-01-01

Propranolol
    Indication: Product Used FOR Unknown Indication

Tetrabenazine
    Dosage: 4.5 milligram;
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Fenofibrate; Ramipril; Atorvastatin; Beconase; Omeprazole; Acrivastine; Bendroflumethiazide



Possible Mirtazapine side effects in female

Reported by a consumer/non-health professional from Denmark on 2012-07-25

Patient: female

Reactions: Akathisia, Muscle Contractions Involuntary, Dyskinesia, Hypophagia, Hallucination, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1 mg;tid
    Indication: Product Used FOR Unknown Indication

Metoclopramide Hydrochloride
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 30 mg;qd
    Indication: Product Used FOR Unknown Indication

Paroxetine HCL
    Dosage: 20 mg;bid;po
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Propranolol HCL
    Dosage: 10 mg;q4h
    Indication: Product Used FOR Unknown Indication

Tetrabenazine (Tetrabenazine)
    Dosage: 4.5 mg;qd
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Beconase; Acrivastine; Omeprazole; Fenofibrate; Bendroflumethiazide; Ramipril; Atorvastatin



Possible Mirtazapine side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-07-25

Patient: female

Reactions: Akathisia, Drug Effect Decreased, Joint Contracture, Adverse Drug Reaction, Dyskinesia, General Physical Health Deterioration, Fall, Hypophagia, Hallucination

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1 mg, tid, dose halved
    Indication: Product Used FOR Unknown Indication

Metoclopramide Hydrochloride
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 30 mg, frequency unspecifieid, 15 mg, qd
    Indication: Product Used FOR Unknown Indication

Paroxetine Hydrochloride

Paroxetine Hydrochloride
    Dosage: 20 mg qd, oral, 20 mg, bid, oral (1 tablet dosage unknown, (half a tablet) (dose and frequency unspe
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01
    End date: 2011-11-01

Propranolol
    Dosage: 10 mg, 6xday
    Indication: Product Used FOR Unknown Indication

Tetrabenazine (Tetrabenazine)
    Dosage: 4.5 mg, qd
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Bendroflumethiazine; Omeprazole; Ramipril; Actrivastine; Fenofibrate; Atorvastatin Calcium; Beconase



Possible Mirtazapine side effects in female

Reported by a individual with unspecified qualification on 2012-07-24

Patient: female

Reactions: Akathisia, Drug Effect Decreased, Joint Contracture, Dyskinesia, Adverse Drug Reaction, General Physical Health Deterioration, Fall, Hypophagia, Hallucination

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 3 mg (1 mg, 3 in 1 d)
    Indication: Product Used FOR Unknown Indication

Metoclopramide
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 30 mg, daily
    Indication: Product Used FOR Unknown Indication

Paroxetine HCL
    Dosage: 40 mg (20 mg, 2 in 1 d), oral, 20 mg (20 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Depression
    Start date: 2011-01-01
    End date: 2011-11-01

Paroxetine HCL
    Dosage: 40 mg (20 mg, 2 in 1 d), oral, 20 mg (20 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Propranolol
    Dosage: 60 mg (10 mg, 6 in 1 d)
    Indication: Product Used FOR Unknown Indication

Tetrabenazine (Tetrabenazine)
    Dosage: 4.5 mg daily
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Beconase; Ramipril; Omeprazole; Acrivastine (Acrivastine); Atorvastatin; Fenofibrate; Bendroflumethiazide (Bendroflumethiazide)



Possible Mirtazapine side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-23

Patient:

Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1 mg, tid

Metoclopramide

Mirtazapine
    Dosage: 15 mg, qd

Mirtazapine
    Dosage: 30 mg, unk

Paroxetine Hydrochloride
    Dosage: 20 mg, bid
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Propranolol Hydrochloride
    Dosage: 10 mg, q4h

Tetrabenazine
    Dosage: 4.5 mg, qd

Other drugs received by patient: Acrivastine; Beconase; Atorvastatin Calcium; Fenofibrate; Ramipril; Bendrofluazide Tablets; Omeprazole



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-06

Patient: female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Overdose, Myoglobin Blood Increased, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1+0+0+1.5 (6 millimoles)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 80 mg
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-07-05

Patient: 72 year old female

Reactions: Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Constipation, Fall, Liver Disorder, Multi-Organ Failure, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Polydipsia, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol;unk;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Curetter; Kalimklorid; Centyl MED



Possible Mirtazapine side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-07-03

Patient: female

Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1mg three times per day
    Indication: Product Used FOR Unknown Indication

Metoclopramide
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 30mg per day
    Indication: Product Used FOR Unknown Indication

Paroxetine Hydrochloride
    Dosage: 20mg twice per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Propranolol
    Dosage: 10mg six times per day
    Indication: Product Used FOR Unknown Indication

Tetrabenazine
    Dosage: 4.5mg per day
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Omeprazole; Ramipril; Bendroflumethiazide; Acrivastine; Fenofibrate; Beconase; Atorvastatin



Possible Mirtazapine side effects in female

Reported by a physician from Denmark on 2012-06-29

Patient: female

Reactions: Osteosynthesis, Humerus Fracture, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-28

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Dyspnoea, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, unk
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl MED Kaliumklorid; Fragmin; Ferro Duretter; Amlodipine Actavis; Alprazolam



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-26

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Lactic Acidosis, Fall, Organ Failure, Multi-Organ Failure, Hyperventilation, Renal Failure, Lacunar Infarction, Depressed Level of Consciousness, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: K CL TAB; Ferro Duretter; Alprazolam



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-22

Patient: female

Reactions: Confusional State, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Lacunar Infarction, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Escitalopram
    Dosage: 30 mg, qd
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Alprazolam; Centyl MED Kaliumklorid; Ferro Duretter



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-22

Patient: 72 year old female

Reactions: Confusional State, Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Pyrexia, Serotonin Syndrome, Constipation, Fall, Hyperventilation, Multi-Organ Failure, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, General Physical Health Deterioration, Organ Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED; Kaliumklorid



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-22

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Confusional State, Osteosynthesis, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl K; Ferro Duretter; Alprazolam



Possible Mirtazapine side effects in female

Reported by a physician from Denmark on 2012-06-22

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cipralex
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Mirtazapine side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-06-20

Patient: female

Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lorazepam
    Dosage: 1mg three times per day
    Indication: Product Used FOR Unknown Indication

Metoclopramide
    Indication: Product Used FOR Unknown Indication

Mirtazapine
    Dosage: 30mg per day
    Indication: Product Used FOR Unknown Indication

Paroxetine Hydrochloride
    Dosage: 20mg twice per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01

Propranolol
    Dosage: 10mg six times per day
    Indication: Product Used FOR Unknown Indication

Tetrabenazine
    Dosage: 4.5mg per day
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Acrivastine; Fenofibrate; Bendroflumethiazide; Beconase; Omeprazole; Ramipril; Atorvastatin Calcium



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-19

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Rhabdomyolysis, Serotonin Syndrome, Lactic Acidosis, Constipation, Fall, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Lacunar Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Alprazolam; K CL TAB



Possible Mirtazapine side effects in female

Reported by a physician from Denmark on 2012-06-15

Patient: female

Reactions: Confusional State, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: styrke: 40 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED Kaliumklorid



Possible Mirtazapine side effects in 88 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-12

Patient: 88 year old female

Reactions: Confusional State, Blood Pressure Systolic Increased, Urinary Tract Infection, Drug Interaction, Abnormal Behaviour, Cognitive Disorder, Disorientation, Fall, Aggression, Incoherent, Blood Sodium Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Imovane (Zopiclone)
    Dosage: 3.75 mg;qd;po
    Administration route: Oral
    Start date: 2012-01-06

Memantine HCL
    Dosage: 10 mg;qd;po
    Administration route: Oral
    Indication: Senile Dementia
    Start date: 2012-01-12
    End date: 2012-01-20

Mirtazapine
    Dosage: 15 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-06

Oxazepam
    Dosage: 10 mg;bid;po
    Administration route: Oral
    Indication: Abnormal Behaviour
    Start date: 2011-12-01

Zyprexa
    Dosage: 5 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-24

Zyprexa
    Dosage: 5 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-11
    End date: 2012-01-20

Other drugs received by patient: Aspirin; Moviprep; Furadantin; Vitamin D; Acetaminophen



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-11

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Fragmin; Ferro Duretter; Amlodipine; Centyl K; Furosemide



Possible Mirtazapine side effects in 85 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-05

Patient: 85 year old female

Reactions: Weight Decreased, Psychomotor Retardation, Blood Pressure Systolic Increased, Hyponatraemia, General Physical Health Deterioration, Cerebral Atrophy, Coma Scale Abnormal, Disorientation, Fall, Mixed Receptive-Expressive Language Disorder, Psychiatric Symptom, Malignant Peritoneal Neoplasm, Asthenia, Blood Glucose Increased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine
    Dosage: 15 mg;qd;po
    Administration route: Oral
    Indication: Depression
    End date: 2012-01-27

Spironolactone
    Dosage: 1 df;qd;po
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-01-27

Stalevo 50
    Dosage: po 5 df;qd;po
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2011-12-01

Stalevo 50
    Dosage: po 5 df;qd;po
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-12-15
    End date: 2012-01-26

Other drugs received by patient: Polyethylene Glycol; Rabeprazole Sodium; Clopidogrel; Imovane; Lactulose; Oxazepam; Pravastatin



Possible Mirtazapine side effects in 88 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-24

Patient: 88 year old female

Reactions: Blood Pressure Increased, Confusional State, Abnormal Behaviour, Drug Interaction, Condition Aggravated, Cognitive Disorder, Disorientation, Fall, Incoherent, Blood Sodium Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Flovent HFA
    Dosage: 5 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-24

Flovent HFA
    Dosage: 5 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-11
    End date: 2012-01-20

Imovane (Zopiclone)
    Dosage: 3.75 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-06

Memantine HCL
    Dosage: 10 mg; qd; po
    Administration route: Oral
    Indication: Senile Dementia
    Start date: 2012-01-12
    End date: 2012-01-20

Mirtazapine
    Dosage: 15 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-06

Oxazepam
    Dosage: 10 mg; bid; po
    Administration route: Oral
    Indication: Abnormal Behaviour
    Start date: 2011-12-01

Other drugs received by patient: Moviprep; Acetaminophen; Aspirin; Vitamin D; Furadantin



Possible Mirtazapine side effects in 33 year old male

Reported by a physician from Japan on 2012-04-20

Patient: 33 year old male

Reactions: Contusion, Toxicity To Various Agents, Fall, Loss of Consciousness, Sedation, Suicide Attempt, Multiple Drug Overdose Intentional, Oxygen Saturation Decreased, Haematoma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine
    Dosage: 15;30 mg, qd, po
    Administration route: Oral
    Indication: Depression
    Start date: 2012-03-06
    End date: 2012-03-26

Mirtazapine
    Dosage: 15;30 mg, qd, po
    Administration route: Oral
    Indication: Depression
    Start date: 2012-02-21
    End date: 2012-03-05

Rohypnol (Flunitrazepam)
    Dosage: 2 mg, qd, po
    Administration route: Oral
    Indication: Depression
    Start date: 2012-02-07
    End date: 2012-03-26

Other drugs received by patient: Duloxetine Hydrochloride; Hydrochloride; Duloxetine Hydrochloride; Flunitrazepam; Duloxetine Hydrochloride; Hydrochloride; Hydrochloride



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-13

Patient: female

Reactions: Humerus Fracture, Dyspnoea, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension, Myocardial Infarction, Cardiac Hypertrophy

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: dosis: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: styrke: 40 mg
    Administration route: Oral
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Amlodipine; Fragmin; Centyl MED Kaliumklorid; Ferro Duretter; Furosemide



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017